Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America. Its Dermatology products include Actikerall, Epuris, Ozanex and Vaniqa. Its Hospital Acute Care products include Aggrastat and Brinavess. Its Out-Licensed products include Absorica, ConZip and Lipofen. The Company is also focused on building a portfolio of prescription medicines that serve unmet medical needs. The Company's product pipeline development programs including MOB-015, DTR-001, and CF-101. The Company's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC, and Cipher Pharmaceuticals US LLC.


TSX:CPH - Post by User

Bullboard Posts
Comment by spike55on Feb 26, 2020 5:25pm
90 Views
Post# 30737899

RE:RE:RE:Looks Like Sun Pharma Is Going All Out on Absorbica LD

RE:RE:RE:Looks Like Sun Pharma Is Going All Out on Absorbica LDTakeovers are great, I have had about 5 total in my lifetime, waking up in the morning with a 30-100% gain is satisfying.

But you know whats better, have a stock that goes up 100% for 5 years in a row, you know what Cipher could be that stock. The current plan is not going to work where they out-source Canada, this was never the problem to begin with. it was the sales team they had in the USA. which they got rid of.

They need to hire a new CEO and CFO, which need to concentrate on Canadian  sales, they also need to outsource submissions to the Canadian drug agency......and get rid of that doctor they have on staff.

Craig Mull needs to give it up and the sooner the better.

I,m not worried about trulance thats a nice little call-option. They need to hire a good lawyer.

Hopefully I can attend the Annual meeting missed last years was on Vacation
Bullboard Posts